Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Gilead Sciences
Gilead Sciences
New fault lines emerge in CAR-T therapy
EP Vantage
Tue, 08/24/21 - 10:43 am
CAR-T
Novartis
Kymriah
Bristol Myers Squibb
Beyanzi
Gilead Sciences
Yescarta
clinical trials
Oral Remdesivir Could Lower COVID Hospitalizations, Preclinical Study Says
BioSpace
Mon, 08/23/21 - 11:29 pm
Gilead Sciences
remdesivir
COVID-19
Gilead, Regeneron, AstraZeneca and more encourage FDA to expand patient reported outcome guidance
Endpoints
Mon, 08/23/21 - 11:07 am
Gilead Sciences
Regeneron
AstraZeneca
FDA
PROs
oncology
clinical trials
patient-reported outcomes
Gilead cements its long-acting HIV ambitions
EP Vantage
Fri, 08/13/21 - 10:51 am
Gilead Sciences
HIV
lenacapavir
clinical trials
Gilead latest biopharma company to require U.S. workers receive COVID-19 vaccine
Yahoo/Reuters
Tue, 08/10/21 - 10:44 am
Gilead Sciences
Pfizer
COVID-19
vaccines
Gilead Foundation bounces back with a bang—$200M in the bank and ambitious goals
Fierce Pharma
Fri, 08/6/21 - 11:09 am
Gilead Sciences
Gilead Foundation
non-profits
With an assist from AstraZeneca, the salvage crew at Sierra bets another $216M they can resurrect an old Gilead JAK drug
Endpoints
Fri, 08/6/21 - 11:07 am
Gilead Sciences
AstraZeneca
Sierra Oncology
AZD5153
oncology
Gilead's Kite, Appia Bio to Collaborate on Allogeneic Cell Therapies for Cancer
Marketwatch
Thu, 08/5/21 - 11:04 am
Gilead Sciences
Kite Pharma
Appia Bio
cancer
cell therapy
Drugs facing the most patent expirations this year
Drug Patent Watch
Sun, 08/1/21 - 11:46 pm
patents
Novartis
Sunovion
Allergan
Bayer
Gilead Sciences
Gilead Earnings Top Views; Biotech Giant Narrows Guidance
Investors Business Daily
Fri, 07/30/21 - 11:03 am
Gilead Sciences
earnings
3 Biotechs That Could Make Big Acquisitions This Year
Motley Fool
Thu, 07/22/21 - 11:10 am
M&A
AbbVie
Vertex Pharmaceuticals
Gilead Sciences
BioNTech returns to cancer roots with deal for Gilead cell therapy factory
BioPharma Dive
Mon, 07/19/21 - 11:10 pm
BioNTech
cancer
Gilead Sciences
Kite Pharma
cell therapy
Gilead's Veklury shows 'no antiviral effects' against COVID-19 in small WHO study
Fierce Pharma
Mon, 07/12/21 - 11:38 pm
Veklury
Gilead Sciences
COVID-19
Gilead, Foresite back biotech developer of COVID-19 pill in latest SPAC deal
BioPharma Dive
Wed, 06/30/21 - 12:11 am
antivirals
COVID-19
Gilead Sciences
Foresite
Pardes Biosciences
Gilead challenges ViiV in resistant HIV, filing twice-yearly therapy
Pharmaforum
Tue, 06/29/21 - 10:52 am
Gilead Sciences
HIV
ViiV Healthcare
FDA
lenacapavir
Rukobia
Biopharma M&A set for a strong H2 despite political noise—and Biogen and Gilead look like buyers: analysts
Fierce Pharma
Mon, 06/28/21 - 11:54 am
M&A
Joe Biden
Biogen
Gilead Sciences
oncology
gene therapy
Gilead's Kite earns second-line win for CAR-T Yescarta, setting up a battle over earlier blood cancer patients
Endpoints
Mon, 06/28/21 - 10:51 am
Gilead Sciences
Kite Pharma
Yescarta
relapsed or refractory diffuse large B-cell lymphoma
CAR-T
Gilead preps filing for hepatitis D therapy Hepcludex in US
Pharmaforum
Fri, 06/25/21 - 11:03 am
Gilead Sciences
Hepcludex
hepatitis D
Real-world remdesivir data add to body of evidence for Gilead Sciences Covid-19 drug
MedCity News
Tue, 06/22/21 - 11:09 am
Gilead Sciences
remdesivir
COVID-19
real world data
real world evidence
RWE
8 key clinical trials to watch for the rest of 2021
BioPharma Dive
Mon, 06/21/21 - 11:11 am
clinical trials
Merck
Ridgeback Biotherapeutics
COVID-19
Intellia Therapeutics
transthyretin amyloidosis
Arcus Biosciences
Gilead Sciences
lung cancer
Sanofi
GSK
vaccines
uniQure
Huntington's disease
Mirati Therapeutics
gene editing
Seres Therapeutics
ulcerative colitis
Sarepta Therapeutics
Duchenne Muscular Dystrophy
Pages
« first
‹ previous
…
7
8
9
10
11
12
13
14
15
…
next ›
last »